TCIM
TPST icon

TIAA CREF Investment Management’s Tempest Therapeutics TPST Stock Holding History

TIAA CREF Investment Management’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-33
Closed -$179K – 3176
2017
Q1 		$179K Hold
33
– – ﹤0.01% 3009
2016
Q4 		$148K Hold
33
– – ﹤0.01% 3060
2016
Q3 		$681 Hold
33
– – ﹤0.01% 2732
2016
Q2 		$495K Buy
33
+8
+32% +$183K ﹤0.01% 2859
2016
Q1 		$685K Sell
25
-1
-4% -$21.1K ﹤0.01% 2661
2015
Q4 		$737K Sell
26
-1
-4% -$33K ﹤0.01% 2753
2015
Q3 		$664K Hold
27
– – ﹤0.01% 2794
2015
Q2 		$2.31M Buy
27
+3
+13% +$275K ﹤0.01% 2210
2015
Q1 		$2.45M Buy
24
+2
+9% +$266K ﹤0.01% 2105
2014
Q4 		$2.89M Buy
22
+1
+5% +$73.2K ﹤0.01% 2004
2014
Q3 		$1.03M Sell
21
-1
-5% -$35.1K ﹤0.01% 2607
2014
Q2 		$590K Buy
22
+10
+83% +$236K ﹤0.01% 2970
2014
Q1 		$325K Hold
12
– – ﹤0.01% 3034
2013
Q4 		$332K Sell
12
-3
-20% -$82.3K ﹤0.01% 3041
2013
Q3 		$422K Sell
15
-1
-6% -$35.5K ﹤0.01% 2975
2013
Q2 		$661K Buy
+16
New +$601K ﹤0.01% 2823

Other funds holding TPST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TIAA CREF Investment Management's TPST Position: Q2 2017 in Review

TIAA CREF Investment Management sold out of Tempest Therapeutics (TPST) in Q2 2017, closing a stake of 33 shares — an estimated $179K sold.

TIAA CREF Investment Management first reported a position in TPST in Q2 2013 and held it in 16 quarters. The position peaked at $2.89M in Q4 2014. 54 funds tracked by Wall St. Rank hold TPST as of Q2 2017.

  • TIAA CREF Investment Management reported no remaining Tempest Therapeutics position as of Q2 2017 after selling out during the quarter.
  • TIAA CREF Investment Management sold 33 Tempest Therapeutics shares in Q2 2017, an estimated $179K.
  • TIAA CREF Investment Management first reported a position in Tempest Therapeutics in Q2 2013 and held it in 16 quarters.
  • TIAA CREF Investment Management's Tempest Therapeutics position peaked at $2.89M in Q4 2014.
  • 54 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2017.

Based on TIAA CREF Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.